Crossmark

Species identification and drug susceptibility testing of non-tuberculous mycobacteria by Line Probe Assay in Lambaréné, Gabon—a cross-sectional study

Crossref DOI link: https://doi.org/10.1186/s12879-023-08617-x

Published Online: 2023-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ndanga, Micheska Epola Dibamba

Abdul, Jabar Babatundé Pacome Achimi Agbo

Edoa, Jean Ronald

Ibinda, Guy Arnault Rogue Mfoumbi

Adegbite, Bayodé Romeo

Mevyann, Rhett Chester

Biyogho, Christopher Mebiame

Mahoumbou, Jocelyn

Manguinga, Stredice

Roguet, Nina Mbenga

Lell, Bertrand

Kremsner, Peter Gottfried

Alabi, Abraham Sunday

Grobusch, Martin Peter

Adegnika, Ayola Akim
License Information

Text and Data Mining valid from 2023-10-03

Version of Record valid from 2023-10-03
More Information

Article History

Received: 21 May 2023

Accepted: 18 September 2023

First Online: 3 October 2023

Declarations

:

: The study protocol was approved by the Institutional Ethics Committee of the Centre de Recherches Médicales de Lambaréné (CERMEL) under the number CEI-014-2019. Written informed consent was obtained from all volunteers prior to study, study identification numbers and laboratory serial numbers were used instead of patient numbers. names so that the identity of each participant remains completely anonymous.All work on human tissue samples, and human data reporting in the manuscript were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below